CorMedix Inc. is a biopharmaceutical company headquartered in Berkeley Heights, New Jersey, specializing in the development and commercialization of innovative therapies for infectious and inflammatory diseases. The company is committed to addressing critical unmet medical needs, particularly in infection control and inflammatory conditions. With a robust pipeline of products aimed at improving patient outcomes, CorMedix is strategically positioned to impact the global healthcare landscape significantly. Its focus on innovative solutions ensures relevance in an increasingly competitive market, appealing to institutional investors looking for growth in healthcare innovation.
Click "Analyze" to generate stock analysis
CRMD Price Trend and Signals
CRMD Option Volumes & Open Interests (aggregated)
CRMD Put Call Ratios and IV (aggregated)
CRMD Financials
2025-10-20Bullishmacd_signal
Golden cross below zero detected.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-20Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-20Somewhat Bullishprice_signal
Monthly high detected.
2025-10-20Bullishprice_signal
Large price change detected: 19.45%.
2025-10-20Neutraloption_volume_signal
Abnormal option volume detected compared to 5-day moving average.